Premium Information is available for this item - Upgrade for $1 a day
6505-00-201-2521
Usp Ethosuximide Capsules
6505002012521 002012521 ZAR0NTIN 71-237-4 7-237-4
November 2023
8
Marketplace 6505-00-201-2521
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-201-2521 5+ Documents (More...)
Usp Ethosuximide Capsules 6505002012521 Account Upgrade 6505-00-201-2521Usp Ethosuximide Capsules6505002012521
002012521 ZAR0NTIN 71-237-4 7-237 CYLZ]100.000 NATO Stock Numbers Related to 6505-00-201-2521 6505-00
Usp Ethosuximide Capsules 6505002012521 6505-00-201-2521 6505002012521 002012521 ETHOSUXIMIDE CAPSULES
Usp Ethosuximide Capsules 6505002012521 6505-00-201-2521 6505002012521 002012521 ETHOSUXIMIDE CAPSULES
Usp Ethosuximide Capsules 6505002012521 6505-00-201-2521 6505002012521 002012521 ETHOSUXIMIDE CAPSULES
Usp Ethosuximide Capsules 6505002012521 6505-00-201-2521 6505002012521 002012521 ETHOSUXIMIDE CAPSULES
Restrictions 6505-00-201-2521
6505-00-201-2521 is a Usp Ethosuximide Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-201-2521
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-201-2521
- Part Number
- Manufacturer
- Status
- 7-237-4
- Manufacturer
- 91378 - Parke-Davis (Active)
- Original Design
- Original Design
- ZAR0NTIN
- 91378 - Parke-Davis (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- 71-237-4
- 91378 - Parke-Davis (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6505-00-201-2521
- Characteristic
- Specifications
- Capsule Type [AKJC]
- Specifications
- Soft
- Capsule Content Form [CQLS]
- Liquid
- Active Medicament Medicinal Strength [AKJA]
- 250.000 Milligrams Ethosuximide Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 100.000
NATO Stock Numbers Related to 6505-00-201-2521
Freight Information 6505-00-201-2521
6505-00-201-2521 has freight characteristics.. 6505-00-201-2521 has a variance between NMFC and UFC when transported by rail and the description should be consulted.